Treatment of Agitation in Individuals With Bipolar Disorder or Schizophrenia: Lessons Learned for Clinical Psychiatry and Psychiatric Drug Development

PRESKORN: Kansas University School of Medicine-Wichita, Wichita, KS

Over his 40-year career, S.H.P. has worked with over 140 pharmaceutical and biotech companies in the United States and throughout the world. Over the past year, he has received grants/research support from or has served as a consultant, on the advisory board, or on the speaker’s bureau for Alkermes, BioXcel, Eisai, Janssen, Otsuka, Sunovion, and Usona Institute. All clinical trial and study contracts were with and payments made to the Kansas University Medical Center Research Institute, a research institute affiliated with Kansas University School of Medicine-Wichita.

Please send correspondence to: Sheldon H. Preskorn, MD, Kansas University School of Medicine-Wichita, 1010 North Kansas Street, Wichita, KS 67214.

留言 (0)

沒有登入
gif